Acción A007460 APROGEN MEDICINES INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Aprogen Medicines Inc.

Acciones

A007460

KR7007460009

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 03/05/2024 		Varia. Cinco días. Varia. 1 de enero.
1.488 KRW +0,27 % Gráfico intradía de Aprogen Medicines Inc. +0,20 % +55,00 %
19/03 Aprogen Medicines Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023 CI
2023 Aprogen Medicines Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor
Aprogen KIC Inc. announced that it expects to receive KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A007460
  4. Noticias Aprogen Medicines Inc.
  5. Otros idiomas